ClinicalTrials.govpublic full text
Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs
schizophrenia, schizoaffective disorder, bipolar disorder, mental disorders, antipsychotic agents, magnesium, cardiovascular risk factor, metabolic syndrome, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 911175
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.